N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Biochemistry and Cell Biology

• Publication date

  2010-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biocel.2010.09.008PMID 20854925PMCID PMC2982800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.

  2010cited by this paper
• Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.

  2010cited by this paper
• Tumorigenesis and Neoplastic Progression Stat 3 Promotes Metastatic Progression of Prostate Cancer

  2010cited by this paper
• Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.

  2010cited by this paper
• Transcription Factor Signal Transducer and Activator of Transcription 5 Promotes Growth of Human Prostate Cancer Cells In vivo

  2008cited by this paper
• Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B.

  2008cited by this paper
• Signal transducer and activator of transcription 5 A / B in prostate and breast cancers

  2008cited by this paper
• Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

  2008cited by this paper
• JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

  2007cited by this paper
• Purification and identification of the STAT5 protease in myeloid cells.

  2007cited by this paper
• Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.

  2007cited by this paper
• PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.

  2007cited by this paper
• Regulation of cytokine signaling pathways by PIAS proteins

  2006cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

  2005cited by this paper
• A gain-of-function mutation of JAK2 in myeloproliferative disorders.

  2005cited by this paper
• Activation of Signal Transducer and Activator of Transcription-5 in Prostate Cancer Predicts Early Recurrence

  2005cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

  2005cited by this paper
• Expression of Androgen Receptor Coregulators in Prostate Cancer

  2004cited by this paper
• Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential

  2004cited by this paper
• Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade

  2004cited by this paper
• Differential PIAS3 expression in human malignancy.

  2004cited by this paper
• PIAS/SUMO: new partners in transcriptional regulation

  2003cited by this paper
• Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells*

  2003cited by this paper
• Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.

  2002cited by this paper
• PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro.

  2002cited by this paper
• Signaling through the JAK/STAT pathway, recent advances and future challenges.

  2002cited by this paper
• PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro.

  2002cited by this paper
• Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer.

  2002cited by this paper
• The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer

  2002cited by this paper
• Signalling: STATs: transcriptional control and biological impact

  2002cited by this paper
• Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells

  2001cited by this paper
• The Stat family in cytokine signaling.

  2001cited by this paper
• Generation of carboxy-terminally deleted forms of STAT5 during preparation of cell extracts.

  1999cited by this paper
• The Significance of Tetramerization in Promoter Recruitment by Stat5

  1999cited by this paper
• Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.

  1998cited by this paper
• Three-dimensional structure of the Stat3β homodimer bound to DNA

  1998cited by this paper
• Functionally distinct isoforms of STAT5 are generated by protein processing.

  1997cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization.

  1994cited by this paper
• Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation.

  1992cited by this paper

• Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer

  2025cites this paper
• Integrative analysis revealed a correlation of PIAS family genes expression with prognosis, immunomodulation and chemotherapy

  2024cites this paper
• GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC

  2023cites this paper
• Therapeutic Potential of Targeting the SUMO Pathway in Cancer

  2021cites this paper
• Dissecting multiple roles of SUMOylation in prostate cancer.

  2021cites this paper
• The role of JAK/STAT signaling pathway and its inhibitors in diseases.

  2020cites this paper
• JAK/STAT pathway and molecular mechanism in bone remodeling

  2020cites this paper
• Prolactin Receptor Isoforms as the Basis of Tissue-Specific Action of Prolactin in the Norm and Pathology

  2019cites this paper
• A Hierarchical Machine Learning Model to Discover Gleason Grade-Specific Biomarkers in Prostate Cancer

  2019cites this paper
• Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.

  2017cites this paper
• Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

  2016cites this paper
• Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.

  2015cites this paper
• Evaluation von mTOR und STAT5b als potentielle Zielstrukturen zur Behandlung des duktalen Adenokarzinom des Pankreas

  2015cites this paper
• Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells

  2015cites this paper
• Association of sedentary behavior with the expression levels of biomarkers in colorectal cancer: clinical analysis of 228 patients.

  2014cites this paper
• Role of human Desmoglein 3 in the regulation of cell morphology and motility via AP-1 and PKC dependent Ezrin activation

  2014cites this paper
• Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6–Induced Experimental Prostate Cancer Metastases Formation

  2014cites this paper
• Construction of expression vector of siRNA specific for STAT5a and identification of its efficiency in MGC803 gastric cancer cell line

  2014cites this paper
• Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer

  2014cites this paper
• PIAS3 may represent a potential biomarker for diagnosis and therapeutic of human colorectal cancer.

  2013cites this paper
• Pharmacologic Inhibition of Jak2–Stat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer

  2013cites this paper
• Design and Synthesis of New Scaffolds for Stat5 Inhibition

  2013cites this paper
• The Role of Prolactin in the Evolution of Prostate Cancer

  2012cites this paper
• Alternative ways of modulating JAK-STAT pathway

  2012influential citation
• Progress towards direct inhibitors of Stat5 protein

  2012cites this paper
• Inhibitors of Stat5 protein signalling

  2012cites this paper
• Prolactin in breast and prostate cancer: molecular and genetic perspectives.

  2011cites this paper
• TUMORIGENESIS AND NEOPLASTIC PROGRESSION Jak 2-Stat 5 a / b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer

  year unknowncites this paper